awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36022526-A4641DD3-8284-4472-BAD7-4BF5BBBCD30D
Q36022526-A4641DD3-8284-4472-BAD7-4BF5BBBCD30D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36022526-A4641DD3-8284-4472-BAD7-4BF5BBBCD30D
A phase 2 randomized dose-ranging study of the JAK2-selective inhibitor fedratinib (SAR302503) in patients with myelofibrosis
P2093
Q36022526-A4641DD3-8284-4472-BAD7-4BF5BBBCD30D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36022526-A4641DD3-8284-4472-BAD7-4BF5BBBCD30D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a5cf7273663ffc63e6e62c3b7c8483beea67c62e
P1545
6
http://www.w3.org/2001/XMLSchema#string
P2093
G Gao
http://www.w3.org/2001/XMLSchema#string